MSB

11.8%

$1.57 mesoblast limited

Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment, page-84

First 84 Last

Share
Profile

Follow
bedger

7,912 Posts.

7137

30/04/20

11:39

Post #: 44348350
Share

Originally posted by Cato: ↑

Dear friends,

Probably nobody more frustaded than myself reading this text.
I sold at open at 3.40 making a 6 cents profit.

Of course is good, but that was nor my target at all.

My frustration ?

Yesterday I bought with an average of 3.34 in a complete blind situation where artificially big guys left the rage (like I wrote) between 3.30 or 3.40. means... at that time in the day if I want buy I have no alternative.
I decided buy.

But around 2pm they just withdraw their actions and we all saw the share go backwards to 3.16.

This is a big loss if you buy at 3.34 mainly when u talk about a big volume of shares.

I went sleep really pretty upset.

One side of me said... "try to think like a long holder and who cares if drop 20 cents ? suddenly this share will flight...
But the other side, the one that learnt (losing hips) told me.... Wrong shot mate... wrong shot.... you should sell at first 1% backwards...

well..

Probably my internal discussion are familiar to many of you that buy and sell shares .

Today when I saw the open and read the announcement and read this fake Gilead non sense texts all around I thought... Uowwww that's it... just place several orders and get rid even if is 3.30

I did well... but I'm not happy.(in spite when u trade you get use to make few cents up or down.

Why i'm not happy ?

Because I'm under the impression the existence of a major player that is manipulating the stok in such way that jeopardise inclusive the normal movement of buy-sell.

Now, I'm exactly in position of so so so many other people and look the MSB share so carefully that even with amazing good news amazing upside amazing high chances to really see the facts promote a fair share price (that should be REALLY much higher than we are..

But you all can see.... we start 3.40 .. 3.35.... 3.30... is absolutely disgusting .

Well… I will be waiting next entry point and like always, running a risk to lose completly the trend.

Cato

Expand

Wrong thread mate. You want MSB trading or Timber. This is for people who look at the fundamentals here, Who know what an Interleukin-6 inhibitor is (and if you don't why are you trading this).

MSB Price at posting: $3.28 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

First 84 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.57		Change -0.210(11.8%)		Mkt cap ! $1.792B

Open	High	Low	Value	Volume
$1.72	$1.74	$1.52	$15.63M	9.716M

Buyers (Bids)

No.	Vol.	Price($)
1	5127	$1.57

Sellers (Offers)

Price($)	Vol.	No.
$1.57	39613	3

View Market Depth

No.	Vol.	Price($)
1	5127	1.565
3	15000	1.560
2	8950	1.545
3	52000	1.540
1	100000	1.525

Price($)	Vol.	No.
1.570	14365	2
1.580	57756	6
1.585	5500	1
1.590	3123	1
1.600	5000	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)

MSB (ASX) Chart

Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment, page-84

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Banshee's historic trenches prove rich in antimony and gold for GDM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment, page-84

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Banshee's historic trenches prove rich in antimony and gold for GDM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News